ArticleBreast cancer research and treatment2025

Beyond endocrine resistance: estrogen receptor (ESR1) activating mutations mediate chemotherapy resistance through the JNK/c-Jun MDR1 pathway in breast cancer.

Marwa Taya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.